ICER Announces New Governance Board Members in Push to Improve Drug Pricing and Health Equity

March 22, 2021

ICER (the Institute for Clinical and Economic Review) has announced the election of two members to its Governance Board: Joy Lewis, MSW, MPH and Chris Jennings. Joy Lewis is Senior Vice President of the American Hospital Association’s health equity strategies arm and Chris Jennings is President and Founder of Jennings Policy Strategies. He also has an extensive background in health policy and has worked closely with several presidents. These two new members are expected to drive affordable pricing and health equity aims in the organization.

According to Ms. Lewis, “The ongoing pandemic has only reinforced that the US health system has a long way to go to reduce disparities and achieve more fair access to high-quality care across all communities and patient populations. Historically, negotiations over drug pricing and insurance coverage have happened among corporate interests behind closed doors, and I strongly support ICER’s ability to force these conversations out into the open, where a diverse set of patient voices can participate. It is through transparent, evidence-based efforts like these that we can all make US health care more just.” Read more here.